[1]
Steele, S.S. 2013. Botulinum toxin A: First-line therapy for idiopathic detrusor overactivity. Canadian Urological Association Journal. 5, 3 (Apr. 2013), 204–9. DOI:https://doi.org/10.5489/cuaj.644.